TCL Archive RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment September 27, 2013
TCL Archive Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors. October 26, 2001